You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Psoriatic arthritis
SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017100
Jul 20171600
Aug 20171200
Sep 20171602
Oct 20173002
Nov 20173201
Dec 20171000
Jan 20182607
Feb 20186002
Mar 20183000
Apr 20181000
May 20181401
Jun 2018800
Jul 2018600
Aug 20181600
Sep 20181201
Oct 20181601
Nov 20181603
Dec 20182201
Jan 20191401
Feb 2019901
Mar 20192002
Apr 20192102
May 20192801
Jun 20194205
Jul 20192404
Aug 20194401
Sep 20191602
Oct 20193003
Nov 20192402
Dec 20193002
Jan 20201004
Feb 2020200
Mar 20201206
Apr 2020804
May 2020602
Jun 20202001
Jul 20203203
Aug 20201804
Sep 20202600
Oct 20201402
Nov 20201004
Dec 20201803
Jan 20211201
Feb 20211602
Mar 20211204
Apr 20211002
May 20211202
Jun 2021001
Jul 2021009
Aug 2021003
Sep 2021001
Oct 20218013
Nov 2021608
Dec 20211001
Jan 2022100
Feb 2022801
Mar 2022601
Apr 2022401
May 20221208
Jun 20222402
Jul 20221000
Aug 2022801
Sep 20221006
Oct 2022603
Nov 2022607
Dec 2022800
Jan 20233301
Feb 2023801
Mar 2023601
Apr 2023002
May 2023005
Jun 2023400
Jul 2023406
Aug 2023002
Sep 2023400
Oct 2023100
Nov 2023400
Dec 20231201
Jan 20241501
Feb 2024400
Mar 2024401
Total11190178